亚洲依依成人综合网站,手机看片国内基地,日本性爱视频大全在线观看,秋水一色性福利导航,欧美A级V片在线观看,韩国论理片,欧美特色AAA大片,6一12泑女WWW,肥臀喷水上位

產(chǎn)品中心

Product center

Tariquidar 98%

Tariquidar

源葉(MedMol)
S80527
206873-63-4
C38H38N4O6
646.73
品牌 貨號(hào) 產(chǎn)品規(guī)格 價(jià)格(RMB) 庫(kù)存(上海) 北京 武漢 南京 購(gòu)買(mǎi)數(shù)量
源葉(MedMol) S80527-5mg 98% ¥320.00元 9 - - -
源葉(MedMol) S80527-10mg 98% ¥560.00元 6 - - -
源葉(MedMol) S80527-50mg 98% ¥1760.00元 4 - - -
源葉(MedMol) S80527-100mg 98% ¥3200.00元 1 - - -
產(chǎn)品介紹 參考文獻(xiàn)(2篇) 質(zhì)檢證書(shū)(COA) 摩爾濃度計(jì)算器 相關(guān)產(chǎn)品

產(chǎn)品介紹

Tariquidar (XR9576) is a potent and specific inhibitor of P-glycoprotein (P-gp) with the high affinity (Kd=5.1 nM)
產(chǎn)品描述: Tariquidar (XR9576) is a potent and specific inhibitor of P-glycoprotein (P-gp) with the high affinity (Kd=5.1 nM)
靶點(diǎn): Kd: 5.1 nM (P-gp);P-gp
體內(nèi)研究:
In mice bearing the intrinsically resistant MC26 colon tumors, coadministration of Tariquidar (XR9576) potentiates the antitumor activity of Doxorubicin without a significant increase in toxicity; maximum potentiation is observed at 2.5-4.0 mg/kg dosed either i.v. or p.o. In addition, coadministration of Tariquidar (6-12 mg/kg p.o.) fully restores the antitumor activity of Paclitaxel, Etoposide, and Vincristine against two highly resistant MDR human tumor xenografts (2780AD, H69/LX4) in nude mice. Tariquidar is found to also significantly potentiate the antitumor activity of doxorubicin against s.c. MC26 tumors in vivo
參考文獻(xiàn):
1. Martin C, et al. The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein. Br J Pharmacol, 1999, 128(2), 403-411. 2. Mistry P, et al. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Cancer Res, 2001, 61(2), 749-758. 3. Zimmermann ES, et al. Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration. Antimicrob A 4. Kao YH, et al. Regulation of P-glycoprotein expression in brain capillaries in Huntington's disease and its impact on brain availability of antipsychotic agents risperidone and paliperidone. J Cereb Blood Flow Metab. 2016 Aug;36(8):1412-23. 5. Matzneller P, et al. Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration. Eur J Drug Metab Pharmacokinet. 2018 Apr 3.
溶解性: DMSO  :  25  mg/mL  (38.66  mM;  ultrasonic  and  adjust  pH  to  5  with  HCl)    DMSO  :  16  mg/mL  (24.74  mM;  ultrasonic  and  warming  and  adjust  pH  to  3  with  HCl  and  heat  to  60°C)    H2O  :  <  0.1  mg/mL  (insoluble)
保存條件: -20℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 1.546 ml 7.731 ml 15.462 ml
5 mM 0.309 ml 1.546 ml 3.092 ml
10 mM 0.155 ml 0.773 ml 1.546 ml
50 mM 0.031 ml 0.155 ml 0.309 ml
注意: 部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶(hù)參考交流研究之用。

質(zhì)檢證書(shū)(COA)

如何獲取質(zhì)檢證書(shū)(COA)?
請(qǐng)輸入貨號(hào)和一個(gè)與之匹配的批號(hào)。
例如:
批號(hào):C10000001 貨號(hào):A800001-25g
在貨品標(biāo)簽上如何找到貨號(hào)和批號(hào)?

摩爾濃度計(jì)算器

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×

相關(guān)產(chǎn)品